Company intelligence / Profile preview
Vividion Therapeutics
- Ownership
- Private
- Employees
- ~250
- Development stage
- Preclinical
Overview
Vividion Therapeutics has advanced multiple novel small molecule drug candidates into clinical trials using its proprietary chemoproteomic platform. The company has demonstrated the ability to discover covalent allosteric inhibitors for challenging targets such as WRN helicase, with at least one program progressing rapidly into the clinic. Its pipeline includes highly selective therapeutics targeting previously inaccessible disease-causing proteins in oncology and immunology. The breadth of its pipeline spans several programs at various stages of development, though specific late-stage results are not detailed in public sources.[1][8]
- Therapeutic areas
- OncologyImmunologyNeurology
- Modalities
- Small molecules (covalent and allosteric inhibitors)[1][3][8]
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Vividion Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vividion Therapeutics.